Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A guide to CAR T cell therapies: development, current status and future prospects.
Journal: Nature reviews. Immunology
Published: June 01, 2026
Potentiating CAR-T bystander killing by enhanced Fas/FasL signaling mitigates antigen escape in heterogeneous tumors.
Journal: bioRxiv : the preprint server for biology
Published: October 03, 2025
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells.
Journal: Nature
Published: May 16, 2024
Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming.
Journal: Journal for immunotherapy of cancer
Published: June 21, 2023
Outcomes with panobinostat in heavily pretreated multiple myeloma patients.
Journal: Seminars in oncology
Published: December 02, 2022
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity.
Journal: Nature communications
Published: August 24, 2021
A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy.
Journal: Cancer discovery
Published: May 27, 2020
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination.
Journal: Nature medicine
Published: August 14, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026